Effect of a Post-operative Protocol of Early Mobilization on Functional Recovery and Postoperative Complications After Immediate Internal Pudendal Artery Perforator Flap Reconstruction for Irradiated Abdominoperineal Resection Defects: a Prospective, Randomized and Controlled Clinical Study.
1 other identifier
interventional
32
1 country
1
Brief Summary
Major abdominal oncology surgery is associated with substantial postoperative loss of functional capacity, and exercise may be an effective intervention to improve outcomes. The aim of this study was to assess efficacy, feasibility and safety of a supervised postoperative exercise programme in patients undergoing immediate internal pudendal artery perforator flap reconstruction for irradiated abdominoperineal resection defects. We will perform a open label, parallel-arm, randomized trial in patients who underwent immediate internal pudendal artery perforator flap reconstruction for irradiated abdominoperineal resection defects in a tertiary university hospital. Patients will be randomized to an early mobilization postoperative programme based on supervised aerobic exercise, resistance and flexibility training or to standard rehabilitation care - bed restriction for 5 days. The primary outcome will be inability to walk without human assistance at postoperative day 5 or hospital discharge.The secondary outcomes will be incidence of surgical complications, ability of walk assessed for the 6-minute walk test, incidence and intensity of fatigue measured by Piper's Revised Fatigue Scale, improvement of quality of life measured by EuroQuol-5D-5L Questionnaire, Incidence of deep venous thrombosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 9, 2020
CompletedFirst Submitted
Initial submission to the registry
March 10, 2021
CompletedFirst Posted
Study publicly available on registry
March 12, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2022
CompletedMarch 12, 2021
March 1, 2021
1.8 years
March 10, 2021
March 10, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Capacity of functional walking.
Capacity of functional walking, assessed by the patient's ability to cross the hospital room or the ability to walk 3 meters independently on the 5th postoperative day.
5 days.
Secondary Outcomes (6)
Hospital stay.
30 days.
Postoperative complications.
30 days.
Functional walking capacity, assessed by the 6-minute walk test.
30 days.
Incidence and intensity of fatigue measured by the Piper Revised Fatigue Scale.
30 days.
Quality of life measured by the EuroQol-5D-5L Questionnaire.
30 days.
- +1 more secondary outcomes
Study Arms (2)
Interventional group
ACTIVE COMPARATOREarly mobilization postoperative programme based on supervised aerobic exercise, resistance and flexibility training or to standard rehabilitation care
Control group
NO INTERVENTIONBed restriction strategy for 5 days
Interventions
Early mobilization strategy adapted after immediate internal pudendal artery perforator flap reconstruction for abdominoperineal resection (intervention group). 1. Trunk control. 2. Orthostatism. 3. Walk training. 4. Aerobic exercises. 5. Muscle strengthening.
Eligibility Criteria
You may qualify if:
- Patients undergoing immediate internal pudendal artery perforator flap reconstruction for abdominoperineal resection .
- Age ≥ 18 years.
- Agreement to participate and signature of the informed consent form by the patient and / or family.
You may not qualify if:
- Acute myocardial infarction (in the last 30 days) or Unstable angina.
- Uncontrolled cardiac arrhythmia.
- Symptomatic severe aortic stenosis or other symptomatic severe valve dysfunction.
- Congestive heart failure NYHA III or IV.
- Hemodynamic instability.
- Venous thromboembolism.
- Pericarditis, endocarditis or myocarditis.
- Aortic dissection.
- Septic shock.
- Need for renal replacement therapy.
- Thyrotoxicosis.
- Presence of bone metastasis.
- Osteomioarticular and neurological conditions that make it impossible to carry out the exercise program designed for this study.
- Palliative procedures.
- Inability to perform the exercises due to musculoskeletal or neurological changes.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Caio Araujo
São Paulo, 01246-000, Brazil
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 10, 2021
First Posted
March 12, 2021
Study Start
March 9, 2020
Primary Completion
December 31, 2021
Study Completion
July 1, 2022
Last Updated
March 12, 2021
Record last verified: 2021-03
Data Sharing
- IPD Sharing
- Will not share